Scynexis (SCYX) Preferred Dividend Payments (2013 - 2014)
Scynexis' (SCYX) quarterly Preferred Dividend Payments came in at -$1.1 million in Q4 2014, up 80.35% YoY from -$622690.2 in Q4 2013, and down 528.63% on a QoQ basis from $262000.0 in Q2 2014.
Scynexis (SCYX) Preferred Dividend Payments (2013 - 2014) Analysis & Trends
Scynexis (SCYX) has 2 years of Preferred Dividend Payments data on file, last reported at -$1.1 million in Q4 2014.
- Quarterly Preferred Dividend Payments rose 80.35% year-over-year to -$1.1 million in Q4 2014, while the trailing twelve-month figure through Sep 2015 was -$1.1 million (up 77.28% YoY) and the FY2014 annual result came in at $510000.0, up 108.93% from the prior year.
- Preferred Dividend Payments slipped to -$1.1 million in Q4 2014, from $262000.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $510000.0 in Q1 2014 to a low of -$5.7 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -1.12 Mn |
| Jun 30, 2014 | 262,000.00 |
| Mar 31, 2014 | 510,000.00 |
| Dec 31, 2013 | -5.71 Mn |